Document:

Warrant for the Purchase of Common Stock dated May 30, 2008

 Exhibit 10.3 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. SUCH SECURITIES MAY
NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT OR THE ISSUER HAS RECEIVED AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
REASONABLY ACCEPTABLE TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT SECURED BY SUCH SECURITIES. 
 eDiets.com, Inc. 
 Warrant for the Purchase of Shares of 
 Common Stock 
  

			
	500,000 Shares	  	May 30, 2008

 FOR VALUE RECEIVED, eDiets.com, Inc., a Delaware corporation (the “Company”), hereby
certifies that Prides Capital Fund I, L.P. or its assigns, is entitled to purchase from the Company, at any time or from time to time commencing on the date hereof (the “Initial Exercise Date”) and expiring at 5:00 P.M., New York City
time, on the ten (10) year anniversary of the Original Issue Date (the “Expiration Date”) FIVE HUNDRED THOUSAND (500,000) fully paid and non-assessable shares of Common Stock, par value $.001 per share, of the Company (the
“Warrant Shares”) for a per share exercise price of $4.25 (the “Per Share Warrant Price”). The Per Share Warrant Price is subject to adjustment as hereinafter provided. Capitalized terms used and not otherwise defined in this
Warrant shall have the meanings specified in Section 8, unless the context otherwise requires. 
 1. Exercise of Warrant.

 (a) This Warrant may be exercised, in whole at any time or in part from time to time, commencing on the Initial Exercise Date and expiring
at 5:00 P.M., New York City time, on the Expiration Date (with the Exercise Notice at the end of this Warrant duly executed) at the address set forth in Section 10 hereof, together with payment of the Per Share Warrant Price multiplied by the
number of Warrant Shares to which such exercise relates made by delivery to the Company of one or more types of Permitted Consideration. 
 (b) If this Warrant is exercised in part, the Company will deliver to the Holder within three Trading Days of the date such Holder delivers to the Company this Warrant and an Exercise Notice, together with the payment of the aggregate Per
Share Warrant Price for such exercise, a new Warrant covering the Warrant Shares that have not been exercised. By the expiration of the third 

 
Trading Day following the Holder’s delivery of a Warrant, together with an Exercise Notice and the payment of the aggregate Per Share Warrant Price for
such exercise, the Company will (i) issue a certificate or certificates in the name of the Holder for the largest number of whole shares of the Common Stock to which the Holder shall be entitled and, if this Warrant is exercised in whole, in
lieu of any fractional share of the Common Stock to which the Holder shall be entitled, pay to the Holder cash in an amount equal to the fair value of such fractional share (determined by reference to the closing sales price of the Common Stock on
the date of the Exercise Notice), and (ii) deliver the other securities and properties receivable upon the exercise of this Warrant, or the proportionate part thereof if this Warrant is exercised in part, pursuant to the provisions of this
Warrant. 
 (c) If, by the third Trading Day after the date that the Holder delivers an Exercise Notice, together with the payment of the
aggregate Per Share Warrant Price for such exercise, the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 1(b), then the Holder will have the right to rescind such exercise. 

(d) If, by the third Trading Day after the date that the Holder delivers an Exercise Notice, together with the payment of the aggregate Per Share
Warrant Price for such exercise, the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 1(b), and if after such third Trading Day and prior to the receipt of such Warrant Shares, the Holder
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company
shall (1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying
(A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue by (B) the closing bid price of the Common Stock at the time of the obligation giving rise to such purchase
obligation and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock that would
have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In. 
 (e) If, after the Required Effective Date (as defined in the Registration Rights Agreement) the Warrant Shares to be issued are not registered and
available for resale by the Holder pursuant to a registration statement in accordance with the Registration Rights Agreement, then notwithstanding anything contained herein to the contrary, the Holder may, at its election exercised in its sole
discretion, exercise a portion of this Warrant with respect to an aggregate total of twenty-five percent (25%) of the total Warrant Shares and, in lieu of making a cash payment of Permitted Consideration, elect instead to receive upon such
exercise the “Net Number” of shares of Common Stock determined according to the following formula: 
  

					
	 Net Number =
	 	 (A x B) – (A x C)
 B
	  	

 For purposes of the foregoing formula: 
 A=the total number of Warrant Shares with respect to which this Warrant is then being exercised. 
  

 2 

 B=the average of the closing sales prices for the five Trading Days immediately prior to (but not
including) the day that the Holder delivers the Exercise Notice at issue. 
 C=the Per Share Warrant Price. 
 2. Company’s Option to Change Expiration Date. 
 Notwithstanding anything herein to the contrary, in the event that (i) the closing sales price per share of Common Stock is in excess of 150% of the Per Share Warrant Price (as may be adjusted pursuant to
Section 3) for thirty (30) consecutive Trading Days, (ii) the Warrant Shares are either registered for resale pursuant to an effective registration statement naming the Holder as a selling stockholder thereunder (and the prospectus
thereunder is available for use by the Holder as to all then available Warrant Shares) or freely transferable without volume restrictions pursuant to Rule 144(k) promulgated under the Securities Act, as determined by counsel to the Company pursuant
to a written opinion letter addressed and in form and substance reasonably acceptable to the Holder and the transfer agent for the Common Stock, during the entire sixty (60) Trading Day period referenced in (i) above through the expiration
of the Call Date as set forth in the Company’s notice pursuant to this Section (the “Call Condition Period”), and (iii) the Company shall have complied in all material respects with its obligations under this Warrant and the
Common Stock shall at all times be listed on the AMEX, New York Stock Exchange, the Nasdaq National Market, the Nasdaq Capital Market or the OTC Bulletin Board, then, subject to the conditions set forth in this Section, the Company may, in its sole
discretion, elect to change the Expiration Date for the respective Warrant to 5:00 P.M., New York City time on the date that is thirty (30) days after written notice thereof (a “Call Notice”) is received by the Holder (the “Call
Date”) at the address last shown on the records of the Company for the Holder or given by the Holder to the Company for the purpose of notice; provided, that the conditions to giving such notice must be in effect at all times during the Call
Condition Period or any such notice shall be null and void. Notwithstanding anything herein to the contrary, if the Company changes the Expiration Date pursuant to this Section 2, the Holder may, at its election exercised in its sole
discretion, exercise a portion of this Warrant with respect to an aggregate total (including any exercises made under Section 1(e)) of twenty-five percent (25%) of the total Warrant Shares and, in lieu of making a cash payment of Permitted
Consideration, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the formula set forth in Section 1(e). 
 3. Certain Adjustments. The Per Share Warrant Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 3. 
 (a) If the Company, at any time while this Warrant is outstanding, (i) pays a
stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or
(iii) combines outstanding shares of Common Stock into a smaller 

  

 3 

 
number of shares, then in each such case the Per Share Warrant Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall
become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective
immediately after the effective date of such subdivision or combination. 
 (b) If, at any time while this Warrant is outstanding,
(1) the Company effects any merger or consolidation of the Company with or into another person, (2) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (3) any tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, or (4) the Company effects any
reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a “Fundamental Transaction”),
then thereafter this Warrant shall represent the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction
if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the “Alternate Consideration”). For purposes of any such exercise, the
determination of the Per Share Warrant Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Per Share Warrant Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any
choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. At the Holder’s option and request, any successor to the Company or surviving entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the Holders of Common Stock are
entitled to receive as a result of such Fundamental Transaction) in such Fundamental Transaction shall, either (1) issue to the Holder a new warrant substantially in the form of this Warrant and consistent with the foregoing provisions and
evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Per Share Warrant Price upon exercise thereof, or (2) purchase the Warrant from the Holder for a purchase price, payable in cash within five trading
days after such request (or, if later, on the effective date of the Fundamental Transaction), equal to the Black Scholes value of the remaining unexercised portion of this Warrant on the date of such request. The terms of any agreement pursuant to
which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the Holders of Common
Stock are entitled to receive as a result of such Fundamental Transaction) to comply with the provisions of this paragraph (b) and insuring that the Warrant (or any such replacement security) will be similarly adjusted upon any subsequent
transaction analogous to a Fundamental Transaction. 
  

 4 

 (c) If, at any time while this Warrant is outstanding, the Company shall issue additional shares of
Common Stock for consideration per share less than the then current market price (determined (a) in the event that the Common Stock is publicly listed, by reference to the closing sales price of the Common Stock on the date of such issue or
(b) in the event that the Common Stock is not publicly listed, by reference to the then current market value of each share of Common Stock as determined by the Board of Directors of the Company in good faith; provided, however, that in the
event of a sale, merger, liquidation, dissolution or winding up of the Company (each, a “Liquidity Event”), current market price means the amount per share payable to the holders of the Common Stock upon the consummation of such Liquidity
Event), then the Per Share Warrant Price of the Warrant Shares shall be reduced, concurrently with such issue, to a price (calculated to the nearest cent) determined by multiplying such Per Share Warrant Price by a fraction, the numerator of which
shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of shares which the aggregate consideration received by the Company for the total number of additional shares of Common Stock so issued would
purchase at the then current fair market price, and the denominator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of such additional shares of Common Stock so issued.
Notwithstanding the foregoing, no adjustment to the Per Share Warrant Price shall be required under this Section 3(c) in connection with the issuance of shares of Common Stock and/or options, warrants or other Common Stock purchase rights and
the Common Stock issued pursuant to such options, warrants or other rights (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof) issued or to be issued after the date hereof to employees,
officers or directors of, or consultants or advisors to the Company or any subsidiary, pursuant to stock purchase or stock option plans or other arrangements that are approved by the board of directors of the Company. Notwithstanding the foregoing,
no adjustment to the Per Share Warrant Price shall be required under this Section 3(c): (i) in connection with the issuance of shares of Common Stock and/or options, warrants or other Common Stock purchase rights and the Common Stock
issued pursuant to such options, warrants or other rights (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof) issued or to be issued after the date hereof to employees, officers or
directors of, or consultants or advisors to the Company or any subsidiary, pursuant to stock purchase, stock option or employee benefit plans or other arrangements that are approved by the board of directors of the Company; (ii) in connection
with a bona fide firm commitment underwritten public offering with a nationally recognized underwriter which generates gross proceeds to the Company in excess of $15 million; (iii) upon conversion of any options, warrants or other rights to
acquire shares of Common Stock that are outstanding on the day immediately preceding the date hereof, provided, however, that the terms of such options, warrants or rights are not amended, modified or changed on or after the date hereof; or
(iv) in connection with shares of Common Stock issued as consideration for the acquisition of another company or business in which the shareholders of the Company do not have a majority ownership interest, which acquisition has been approved by
the board of directors of the Company, provided that after giving effect to such acquisition the Company is the surviving entity. 
 (d) All calculations under this Section 3 shall be made to the nearest cent or the nearest
1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or
for the account of the Company. 
  

 5 

 (e) Upon the occurrence of each adjustment pursuant to this Section 3, the Company at its expense
will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Per Share Warrant Price and adjusted number or type of Warrant Shares
or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. The Company will promptly deliver a copy of
each such certificate to the Holder and to the Company’s transfer agent. 
 4. Fully Paid Stock; Taxes. 
 The Company agrees that the shares of Common Stock represented by each and every certificate for Warrant Shares delivered on the exercise of this Warrant shall at the
time of such delivery, be duly authorized, validly issued and outstanding, fully paid and nonassessable, and not subject to preemptive rights or rights of first refusal, and the Company will take all such actions as may be necessary to assure that
the par value or stated value, if any, per share of the Common Stock is at all times equal to or less than the then Per Share Warrant Price. The Company further covenants and agrees that it will pay, when due and payable, any and all Federal and
state stamp, original issue or similar taxes which may be payable in respect of the issue of any Warrant Share or any certificate thereof to the extent required because of the issuance by the Company of such security. 
 5. Registration Under Securities Act. 
 (a) The Holder shall, with respect to the Warrant Shares, have the registration rights set forth in the Registration Rights Agreement. By acceptance of this Warrant, the Holder agrees to comply with the provisions of the Registration Rights
Agreement. 
 (b) Until the later of (i) such time as the Holder shall be eligible to resell all of its Warrant Shares without volume
restrictions pursuant to Rule 144(k) promulgated under the Securities Act (assuming Holder is not an “affiliate” of the Company, as defined in Rule 144), as evidenced by a legal opinion to such effect delivered by the Company’s
counsel and acceptable to each of the Company’s transfer agent and the Holder, or (ii) the date on which all Warrant Shares have been sold under a Registration Statement or pursuant to Rule 144 (“Rule 144”) as promulgated under
the Securities Act, the Company shall use its reasonable best efforts to file with the Securities and Exchange Commission all current reports and the information as may be necessary to enable the Holder to effect sales of the Warrant Shares in
reliance upon Rule 144 promulgated under the Securities Act. 
 6. Investment Intent; Restrictions on Transferability. 
 (a) The Holder represents, by accepting this Warrant that it understands that this Warrant and any securities obtainable upon exercise of this Warrant
have not been registered for sale under Federal or state securities laws and are being offered and sold to the Holder pursuant to one or more exemptions from the registration requirements of such securities laws. Certificates representing Warrant
Shares may bear the restrictive legend set forth on the first page hereof. The Holder understands that the Holder must bear the economic risk of such Holder’s investment in this Warrant and any Warrant Shares or other securities obtainable upon
exercise of 

  

 6 

 
this Warrant for an indefinite period of time, as this Warrant and such Warrant shares or other securities have not been registered under Federal or state
securities laws and therefore cannot be sold unless subsequently registered under such laws, or an exemption from such registration is available. 
 (b) The Holder, by such Holder’s acceptance of this Warrant, represents to the Company that such Holder is acquiring this Warrant and will acquire any Warrant Shares or other securities obtainable upon exercise of this Warrant for such
Holder’s own account for investment and not with a view to, or for sale in connection with, any distribution thereof in violation of the Securities Act. The Holder agrees that this Warrant and any such Warrant Shares or other securities will
not be sold or otherwise transferred unless (i) a registration statement with respect to such transfer is effective under the Securities Act or (ii) such sale or transfer is made pursuant to one or more exemptions from the Securities Act.
Notwithstanding the foregoing, this Warrant shall not be sold or otherwise transferred, except to an Affiliate (as such term is defined in that certain note and warrant purchase agreement dated as of the date hereof between the Company and Prides
Capital Fund I, L.P., the “Note and Warrant Purchase Agreement”), unless all amounts due under the Notes (as such term is defined in the Note and Warrant Purchase Agreement) have been paid in full. 
 7. Loss, Theft, Destruction or Mutilation of Warrant. 
 Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and of indemnity reasonably satisfactory to the Company, if lost, stolen or destroyed, and upon surrender and cancellation
of this Warrant, if mutilated, the Company shall execute and deliver to the Holder, a new Warrant of like date, tenor and denomination. 
 8.
Warrant Holder Not Stockholder. 
 This Warrant does not confer upon the Holder any right to vote or to consent to or receive notice as a stockholder
of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a stockholder, prior to the exercise hereof; this Warrant does, however, require certain notices to Holders as set forth herein. 
 9. Definitions. 
 In addition to the
terms defined elsewhere in this Warrant, the following terms have the following meanings: 
 “Assignment” shall mean a notice of
assignment substantially in the form of Exhibit A attached hereto. 
 “Business Day” shall mean any day except Saturday,
Sunday and any day that is a federal legal holiday or a day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. 
  

 7 

 “Common Stock” shall mean the Common Stock, par value $.001 per share, of the Company, for
which the Warrant is exercisable and any securities into which such common stock may hereafter be classified. 
 “Exercise Notice”
shall mean a notice substantially in the form of Exhibit C attached hereto. 
 “Holder” shall mean the holder of this
Warrant and “Holders” shall mean the holder of this Warrant and the holders of all other Warrants. 
 “Partial
Assignment” shall mean a notice of partial assignment substantially in the form of Exhibit B attached hereto. 
 “Permitted
Consideration” shall mean cash or other funds immediately available to the Company. 
 “Registration Rights Agreement” shall
mean that certain Registration Rights Agreement, dated as of May 30, 2008, by and between the Company and the parties thereto. 
 “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market (other than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is
traded in the over the counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on the OTC Bulletin Board, a day on which the Common Stock is quoted in the over the counter market as reported by the
National Quotation Bureau Incorporated (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and
(iii) hereof, then Trading Day shall mean a Business Day. 
 “Trading Market” shall mean whichever of the New York Stock
Exchange, the AMEX, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 
 “Warrants” shall mean this Warrant, all similar Warrants issued on the date hereof and all warrants hereafter issued in exchange or
substitution for this Warrant or such similar Warrants. 
 10. Communication. 
 All notices and communications hereunder shall be in writing and shall be deemed to be duly given if sent by registered or certified mail, return receipt
requested, via a national recognized overnight mail delivery service, or by facsimile (provided the sender receives a machine-generated confirmation of successful transmission), if to the Company, to: 
 eDiets.com, Inc. 
 1000 Corporate Drive

 Suite 600 
 Ft. Lauderdale,
Florida 33334 
  

 8 

 Attn: General Counsel 
 Tel: 954-703-6375 
 Fax: 954-727-2601 
 With a copy to (except in the case of Exercise Notices, Assignments and Partial Assignments): 
 Edwards Angell Palmer & Dodge LLP 
 1 N. Clematis Street 
 Suite 400 
 West Palm Beach, Florida 33401 
 Attn: Leslie J. Croland 
 Tel: 561-820-0212 
 Fax: 561-655-8719

 If to the Holder of this Warrant, to such Holder at the address listed on the records of the Company. 
 11. Reservation of Warrant Shares; Listing. 
 The
Company shall at all times prior to the Expiration Date (a) have authorized and in reserve, and shall keep available, solely for issuance and delivery upon the exercise of this Warrant, the shares of the Common Stock and other securities and
properties as from time to time shall be receivable upon the exercise of this Warrant, free and clear of all restrictions on sale or transfer, other than under Federal or state securities laws, and free and clear of all preemptive rights and rights
of first refusal; and (b) use its reasonable best efforts to keep the Warrant Shares authorized for listing on any national securities exchange, the Nasdaq National Market, the Nasdaq Capital Market or the OTC Bulletin Board. 
 12. Headings; Severability. 
 The headings of this
Warrant have been inserted as a matter of convenience and shall not affect the construction hereof. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute
therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant. 
 13. Applicable Law. 
 This Warrant shall be governed by and construed in accordance with the law of the State of Delaware without giving effect to the principles of conflicts of law thereof.

 14. Specific Performance. The Company agrees that the remedies at law of the Holder of this Warrant in the event of any default or
threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not and will not be adequate and that, to the fullest extent permitted by law, such terms maybe specifically enforced by a decree for the
specific performance of any obligation contained herein or by an injunction against a violation of any of the terms hereof or otherwise. 
  

 9 

 15. Amendment, Waiver, etc. 
 Except as expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged or terminated other than by a written
instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought. 
 [Signature
Page Follows] 
  

 10 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly signed by its undersigned duly
authorized officer as of the Original Issue Date first above referenced. 
  

			
	eDiets.com, Inc.
		
	By:	 	 /s/ James A. Epstein

	Name:	 	James A. Epstein
	Title:	 	Secretary

 EXHIBIT A 
 ASSIGNMENT 
 FOR VALUE RECEIVED
                     hereby sells, assigns and transfers unto
                     the foregoing Warrant and all rights evidenced thereby, and does irrevocably constitute and appoint
                                        ,
attorney, to transfer said Warrant on the books of eDiets.com, Inc. 
  

					
	Dated:                     	 	Signature:	 	  

			
		 	Address:	 	  

 EXHIBIT B 
 PARTIAL ASSIGNMENT 
 FOR VALUE RECEIVED
                     hereby assigns and transfers unto
                     the right to purchase
                     shares of the Common Stock, par value $.001 per share, of eDiets.com, Inc. covered by the foregoing Warrant, and a
proportionate part of said Warrant and the rights evidenced thereby, and does irrevocably constitute and appoint
                                        ,
attorney, to transfer that part of said Warrant on the books of eDiets.com, Inc. 
  

					
	Dated:                     	 	Signature:	 	  

			
		 	Address:	 	  

 EXHIBIT C 
 EXERCISE NOTICE 
 The undersigned hereby elects to purchase
                     shares of Common Stock of eDiets.com, Inc. pursuant to the attached Warrant, and, if such Holder is not utilizing the
cashless (or net) exercise provisions set forth in the Warrant, encloses herewith $             in cash, certified or official bank check or checks or other immediately available
funds, which sum represents the aggregate Per Share Warrant Price for the number of shares of Common Stock to which this Exercise Notice relates, together with any applicable taxes payable by the undersigned pursuant to the Warrant. 
 By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that it is an “accredited investor” as defined in Rule 501(a)
under the Securities Act of 1933. 
 The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the
name of:
                                        .

  

					
	Dated:                     	 	  

		 		 	Signature:
			
		 	Name:	 	  

		 	Address:	 	  

		 		 	  

		
		 	Social Security or Tax I.D. Number:Registration Rights Agreement dated May 30, 2008

 EXHIBIT 10.4 
 REGISTRATION RIGHTS AGREEMENT 
 This Registration Rights Agreement (the “Agreement”) is made as of
the date set forth below between eDiets.com, Inc., a Delaware corporation (the “Company”), and Prides Capital Fund I, L.P. (“Holder”). 
 RECITALS 
 A. The Company has sold and issued to the Holder and the Holder has purchased from the Company a
senior secured promissory note in the aggregate principal amount of $2,595,000.00 and a warrant (the “Warrant”) to purchase up to 500,000 shares of the Company’s common stock (the “Warrant Shares”) in a private
placement (the “Offering”). 
 B. The execution and delivery of this Agreement by the Company and the Holder is a condition
to the completion of the Offering. 
 NOW, THEREFORE, the parties hereto agree as follows: 
 1. REGISTRATION PROCEDURES AND EXPENSES. THE COMPANY SHALL: 
 (a) subject to receipt of reasonably necessary information from the Holder, prepare and file with the Securities and Exchange Commission (“SEC”), within fifteen (15) business days after
the closing price of the Company’s common stock (the “Common Stock”) for five (5) consecutive trading days is at least $5.00 per share, as reported by the domestic stock exchange or over-the-counter market on which the
shares of Common Stock are listed (the “Filing Date”), a registration statement (the “Registration Statement”) on Form S-3 (except if the Company is not then eligible to register on Form S-3, in which case such
registration shall be on another appropriate form in accordance herewith) to enable the resale by the Holder from time to time of (x) the Warrant Shares issuable and (y) the shares of Common Stock issued or issuable upon any stock split,
dividend or other distribution, recapitalization or similar event with respect to the foregoing (collectively, the “Registrable Securities”); 
 (b) use its best efforts, subject to receipt of necessary information from each Holder, to
cause the Registration Statement to become effective as soon as practicable, but in no event later than ninety (90) days after the Filing Date (the “Required Effective Date”). If the Registration Statement (x) has not been
filed by the applicable Required Effective Date, (y) has not been declared effective by the SEC on or before the Required Effective Date or (z) is filed and declared effective but shall thereafter cease to be effective or fail to be usable
for its intended purpose without being succeeded within twenty (20) business days (the “Required Cure Date”) by a post-effective amendment to such Registration Statement that cures such failure and that is itself immediately
declared effective, the Company shall, on the business day immediately following the Required Filing Date, Required Effective Date or Required Cure Date, as the case may be, and each 30th day thereafter, make a payment to each Holder as partial compensation for such delay (the “Late Registration Payments”) equal to one percent (1%) of the
purchase price paid for the Warrant Shares and the Warrant purchased by the Holder and not previously sold by the Holder or otherwise registered by the Company pursuant to Section 1(a) or Section 6 until the Registration Statement is filed
or declared effective by the SEC, as the case may be; provided, however, that in no event shall the payments made pursuant to this paragraph (b), if any, exceed in the aggregate twelve percent (12%) of such purchase price. Late Registration
Payments will be prorated on a daily basis during each 30 day period and will be paid to the Holder by wire transfer or check within five business days after the earlier of (i) the end of each thirty day period following the Required Effective
Date, Required Filing Date or Required Cure Date, as applicable or (ii) the effective date of the Registration Statement; 

 (c) use its best efforts to prepare and file with the SEC such amendments and supplements to the
Registration Statement and the prospectus (the “Prospectus”) included as part of the Registration Statement as may be necessary to keep the Registration Statement current and effective for a period ending on the earlier of
(i) the date on which the Holder may sell Registrable Securities pursuant to paragraph (k) of Rule 144 under the Securities Act or any successor rule (“Rule 144”) or (ii) such time as all Registrable Securities
purchased by such Holder in the Offering have been sold pursuant to a registration statement or Rule 144 (the “Effectiveness Period”), and to notify each Holder promptly upon each Registration Statement and each post-effective
amendment thereto, being declared effective by the SEC; 
 (d) furnish to any Holder such number of copies of the Registration
Statements and the Prospectuses (including supplemental prospectuses) as the Holder may reasonably request, in order to facilitate the public sale or other disposition of all or any of the Registrable Securities by the Holder; 
 (e) file documents required of the Company for normal blue sky clearance in states specified in writing by the Holder; provided, however, that the
Company shall not be required to qualify to do business or consent to service of process in any jurisdiction in which it is not now so qualified or has not so consented; 
 (f) bear all expenses (other than underwriting discounts and commissions, if any) in connection with the procedures in paragraph (a) through (e) of this Section 1 and the registration of the
Registrable Securities pursuant to the Registration Statements; 
 (g) advise the Holder, promptly after it shall receive notice or
obtain knowledge of the issuance of any stop order by the SEC delaying or suspending the effectiveness of each Registration Statement or of the initiation of any proceeding for that purpose; and it will promptly use its commercially reasonable
efforts to prevent the issuance of any stop order or to obtain its withdrawal at the earliest possible moment if such stop order should be issued; and 
 (h) with a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit the Holder to sell Registrable Securities to the public without
registration, the Company covenants and agrees to use its commercially reasonable efforts to: (i) make and keep public information available, as those terms are understood and defined in Rule 144, until the earlier of (A) such date as all
of the Holder’s Registrable Securities may be resold pursuant to Rule 144(k) or any other rule of similar effect or (B) such date as all of the Holder’s Registrable Securities shall have been resold; (ii) file with the SEC in a
timely manner all reports and other documents required of the Company under the Securities Act and under the Securities Exchange Act of 1934, as amended (“Exchange Act”); and (iii) furnish to each Holder, (A) a written
statement by the Company that it has complied with the reporting requirements of the Securities Act and the Exchange Act, (B) a copy of the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and
(C) such other information as may be reasonably requested in order to avail the Holder of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration. 
 The Company understands that the Holder disclaims being an underwriter, but acknowledges that a determination by the SEC that the Holder is deemed an
underwriter shall not relieve the Company of any obligations it has hereunder. 
  

 2 

 2. TRANSFER OF REGISTRABLE SECURITIES AFTER REGISTRATION; SUSPENSION. 
 (a) The Holder agrees that it will not effect any disposition of the Registrable Securities that would constitute a sale within the meaning of the
Securities Act of 1933, as amended (the “Securities Act”), other than in transactions exempt from the registration requirements of the Securities Act or as contemplated in any Registration Statement and as described below, and that
it will promptly notify the Company of any material changes in the information set forth in any Registration Statement regarding the Holder or its plan of distribution. 
 (b) Except in the event that paragraph (c) below applies, the Company shall: (i) if deemed necessary by the Company, prepare and file from time to time with the SEC a post-effective amendment to each
Registration Statement or a supplement to the related Prospectus or a supplement or amendment to any document incorporated therein by reference or file any other required document so that such Registration Statement will not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and so that, as thereafter delivered to purchasers of the Registrable Securities being sold
thereunder, such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading; (ii) provide the Holder copies of any documents filed pursuant to Section 2(b)(i); and (iii) upon request, inform each Holder who so requests that the Company has complied with its obligations in Section 2(b)(i)
(or that, if the Company has filed a post-effective amendment to any Registration Statement which has not yet been declared effective, the Company will notify the Holder to that effect, will use its best efforts to secure the effectiveness of such
post-effective amendment as promptly as possible and will promptly notify the Holder pursuant to Section 2(b)(i) hereof when the amendment has become effective). 
 (c) Subject to paragraph (d) below, in the event: (i) of any request by the SEC or any other federal or state governmental authority during the period of effectiveness of any Registration Statement
for amendments or supplements to the Registration Statement or related Prospectus or for additional information; (ii) of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for that purpose; (iii) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the
Registrable Securities for sale in any jurisdiction or the initiation of any proceeding for such purpose; or (iv) of any event or circumstance which necessitates the making of any changes in any Registration Statement or Prospectus, or any
document incorporated or deemed to be incorporated therein by reference, so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; then the Company shall promptly deliver a certificate in writing to the Holder (the “Suspension Notice”) to the effect of the
foregoing and, upon receipt of such Suspension Notice, the Holder will refrain from selling any Registrable Securities pursuant to the Registration Statement (a “Suspension”) until the Holder is advised in writing by the Company
that the current Prospectus may be used, and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in any such Prospectus. In the event of any Suspension, the Company will use its
reasonable best efforts to cause the use of the Prospectus so suspended to be resumed as soon as reasonably practicable after delivery of a Suspension Notice to the Holder. In addition to and without limiting any other remedies 

  

 3 

 
(including, without limitation, at law or at equity) available to the Holder, the Holder shall be entitled to specific performance in the event that the
Company fails to comply with the provisions of this Section 2(c). The Holder covenants that from the date hereof it will maintain in confidence the receipt and content of any Suspension Notice provided in accordance with this paragraph (c)
in accordance with and subject to Section 7.6 of Annex I to the Securities Purchase Agreement. 
 (d) Notwithstanding the foregoing paragraphs of this Section 2, the Company shall use its commercially reasonable efforts to ensure that (i) any Suspension shall not exceed thirty (30) days
individually and Suspensions shall not exceed ninety (90) days in the aggregate, during any twelve month period and (iii) each Suspension shall be separated by a period of at least thirty (30) days from a prior Suspension (each
Suspension that satisfies the foregoing criteria being referred to herein as a “Qualifying Suspension”). In the event that there occurs a Suspension (or part thereof) that does not constitute a Qualifying Suspension, the Company
shall pay to the Holder, on the thirtieth (30th) day following the first day of such Suspension (or the first day of such part), and on each
thirtieth (30th) day thereafter, an amount equal to 1% of the purchase price paid for the Registrable Securities purchased by the Holder and
not previously sold by the Holder (prorated in each such case for partial thirty day periods); provided, however, that in no event shall the payments made pursuant to this paragraph (d), if any, exceed in the aggregate 5% of such purchase price.

 (e) If a Suspension is not then in effect, the Holder may sell Registrable Securities under each Registration Statement, provided
that it complies with any applicable prospectus delivery requirements. Upon receipt of a request therefor, the Company will provide an adequate number of current Prospectuses to the Holder and to any other parties requiring such Prospectuses.

 (f) In the event of a sale of Registrable Securities by the Holder, unless such requirement is waived by the Company in writing,
the Holder must also deliver to the Company’s transfer agent, with a copy to the Company, a Certificate of Subsequent Sale substantially in the form attached hereto as Exhibit A (“Certificate of Subsequent Sale”), so
that the Registrable Securities may be properly transferred. 
 (g) The Company agrees that it shall, immediately prior to each
Registration Statement being declared effective, deliver to its transfer agent an opinion letter of counsel, opining that at any time the Registration Statement is effective, the transfer agent shall issue, in connection with the sale of the
Registrable Securities, certificates representing such Registrable Securities without restrictive legend, provided the Registrable Securities are to be sold pursuant to the Prospectus contained in the Registration Statement and the transfer agent
receives a Certificate of Subsequent Sale. Upon receipt of such opinion, the Company shall cause the transfer agent to confirm, for the benefit of the Holder, that no further opinion of counsel is required at the time of transfer in order to issue
such Registrable Securities without restrictive legend. 
 The Company shall cause its transfer agent to issue a certificate without any
restrictive legend to a purchaser of any Registrable Securities from the Holder, if (a) the sale of such Registrable Securities is registered under the applicable Registration Statement (including registration pursuant to Rule 415 under the
Securities Act) and the Holder has delivered a Certificate of Subsequent Sale to the Transfer Agent; (b) the Holder has provided the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in
comparable transactions, to the effect that a public sale or transfer of such Registrable Securities may be made without registration under the Securities Act; or (c) such Registrable Securities are sold in compliance with Rule 144 under the
Securities Act. In addition, the Company shall, at the request of the Holder, remove the restrictive legend from any Registrable Securities held by the Holder following the expiration of the holding period required by Rule 144(k) under the
Securities Act (or any successor rule). 
  

 4 

 3. INDEMNIFICATION. FOR THE PURPOSE OF THIS SECTION 3: 
 (a) the term “Selling Shareholder” shall mean the Holder and each person, if any, who controls the Holder within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act; 
 (b) the term “Registration
Statement” shall include any final Prospectus, exhibit, supplement or amendment included in or relating to, and any document incorporated by reference in, the applicable Registration Statement (or deemed to be a part thereof) referred to in
Section 1; and 
 (c) the term “untrue statement” shall mean any untrue statement or alleged untrue statement,
or any omission or alleged omission to state in the applicable Registration Statement a material fact required to be stated therein or necessary to make the statements therein, not misleading. 
 (d) (i) The Company agrees to indemnify and hold harmless each Selling Shareholder from and against any losses, claims, damages or liabilities to
which such Selling Shareholder may become subject (under the Securities Act or otherwise) insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon (i) any untrue
statement of a material fact contained in any Registration Statement, (ii) any inaccuracy in the representations and warranties of the Company contained in the Agreement or the failure of the Company to perform its obligations hereunder or
(iii) any failure by the Company to fulfill any undertaking included in any Registration Statement, and the Company will reimburse such Selling Shareholder for any reasonable legal expense or other actual accountable out of pocket expenses
reasonably incurred in investigating, defending or preparing to defend any such action, proceeding or claim; provided, however, that the Company shall not be liable in any such case to the extent that such loss, claim, damage or liability arises out
of, or is based upon, an untrue statement made in such Registration Statement in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Selling Shareholder specifically for use in preparation of the
applicable Registration Statement, or the failure of such Selling Shareholder to comply with the covenants and agreements in Section 2 hereof or any statement or omission in any Prospectus that is corrected in any subsequent Prospectus that was
delivered to the Selling Shareholder prior to the pertinent sale or sales by the Selling Shareholder. 
 (ii) The Holder agrees to
indemnify and hold harmless the Company (and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act, each officer of the Company who signs any Registration Statement and each director of the
Company) from and against any losses, claims, damages or liabilities to which the Company (or any such officer, director or controlling person) may become subject (under the Securities Act or otherwise), insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon, (i) any failure to comply with the covenants and agreements contained in Section 2 hereof, or (ii) any untrue statement of a material fact
contained in the Registration Statement if, and only if, such untrue statement was made in reliance upon and in conformity with written information furnished by or on behalf of the Holder specifically for use in preparation of the Registration
Statement, and the Holder will reimburse the Company (or such officer, director or controlling person), as the case may be, for any reasonable legal expense or other actual accountable out-of-pocket expenses reasonably incurred in investigating,
defending or preparing to defend any such action, proceeding or claim. The obligation to indemnify shall be limited to the net amount of the proceeds received by the Holder from the sale of the Registrable Securities pursuant to the applicable
Registration Statement. 
  

 5 

 (iii) Promptly after receipt by any indemnified person of a notice of a claim or the beginning of
any action in respect of which indemnity is to be sought against an indemnifying person pursuant to this Section 3, such indemnified person shall notify the indemnifying person in writing of such claim or of the commencement of such action, but
the omission to so notify the indemnifying party will not relieve it from any liability which it may have to any indemnified party under this Section 3 (except to the extent that such omission materially and adversely affects the indemnifying
party’s ability to defend such action) or from any liability otherwise than under this Section 3. Subject to the provisions hereinafter stated, in case any such action shall be brought against an indemnified person, the indemnifying person
shall be entitled to participate therein, and, to the extent that it shall elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, shall be entitled to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified person. After notice from the indemnifying person to such indemnified person of its election to assume the defense thereof (unless it has failed to assume the defense thereof and
appoint counsel reasonably satisfactory to the indemnified party), such indemnifying person shall not be liable to such indemnified person for any legal expenses subsequently incurred by such indemnified person in connection with the defense
thereof; provided, however, that if there exists or shall exist a conflict of interest that would make it inappropriate, in the reasonable opinion of counsel to the indemnified person, for the same counsel to represent both the indemnified person
and such indemnifying person or any affiliate or associate thereof, the indemnified person shall be entitled to retain its own counsel at the expense of such indemnifying person; provided, however, that no indemnifying person shall be responsible
for the fees and expenses of more than one separate counsel (together with appropriate local counsel) for all indemnified parties. In no event shall any indemnifying person be liable in respect of any amounts paid in settlement of any action unless
the indemnifying person shall have approved the terms of such settlement; provided that such consent shall not be unreasonably withheld. No indemnifying person shall, without the prior written consent of the indemnified person, effect any settlement
of any pending or threatened proceeding in respect of which any indemnified person is or could reasonably have been a party and indemnification could have been sought hereunder by such indemnified person, unless such settlement includes an
unconditional release of such indemnified person from all liability on claims that are the subject matter of such proceeding. 
 (iv)
If the indemnification provided for in this Section 3 is unavailable to or insufficient to hold harmless an indemnified party under paragraphs 3(d)(i) or 3(d)(ii) above in respect of any losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in
such proportion as is appropriate to reflect the relative fault of the Company on the one hand and the Holder on the other in connection with the statements or omissions or other matters which resulted in such losses, claims, damages or liabilities
(or actions in respect thereof), as well as any other relevant equitable considerations. The relative fault shall be determined by reference to, among other things, in the case of an untrue statement, whether the untrue statement relates to
information supplied by the Company on the one hand or the Holder on the other and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement. The Company and the Holder agree that
it would not be just and equitable if contribution pursuant to this subsection (d) were determined by pro rata allocation (even if the Holder was treated as one entity for such purpose) or by any other method of allocation which does not take
into account the equitable considerations referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in
this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection
(d), the Holder shall not be required to contribute any amount in excess of the amount by which the gross amount received by the Holder from the sale of the Registrable Securities to which such loss relates exceeds the amount of any damages which
the Holder has otherwise been 

  

 6 

 
required to pay by reason of such untrue statement. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Holder’s obligations in this subsection to contribute are several in proportion to their sales of Registrable
Securities to which such loss relates and not joint. 
 The parties to this Agreement hereby acknowledge that they are sophisticated
business persons who were represented by counsel during the negotiations regarding the provisions hereof including, without limitation, the provisions of this Section 3, and are fully informed regarding said provisions. They further acknowledge
that the provisions of this Section 3 fairly allocate the risks in light of the ability of the parties to investigate the Company and its business in order to assure that adequate disclosure is made in each Registration Statement as required by
the Securities Act and the Exchange Act. 
 4. TERMINATION OF CONDITIONS AND OBLIGATIONS. THE CONDITIONS PRECEDENT IMPOSED BY THIS
SECTION 4 UPON THE TRANSFERABILITY OF THE REGISTRABLE SECURITIES SHALL CEASE AND TERMINATE AS TO ANY PARTICULAR NUMBER OF THE REGISTRABLE SECURITIES WHEN SUCH REGISTRABLE SECURITIES SHALL HAVE BEEN EFFECTIVELY REGISTERED UNDER THE SECURITIES
ACT AND SOLD OR OTHERWISE DISPOSED OF IN ACCORDANCE WITH THE INTENDED METHOD OF DISPOSITION SET FORTH IN THE REGISTRATION STATEMENT COVERING SUCH REGISTRABLE SECURITIES OR AT SUCH TIME AS AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY SHALL HAVE
BEEN RENDERED TO THE EFFECT THAT SUCH CONDITIONS ARE NOT NECESSARY IN ORDER TO COMPLY WITH THE SECURITIES ACT. 
 5. INFORMATION
AVAILABLE. SO LONG AS ANY REGISTRATION STATEMENT IS EFFECTIVE COVERING THE RESALE OF REGISTRABLE SECURITIES OWNED BY THE HOLDER, THE COMPANY WILL FURNISH (OR, TO THE EXTENT SUCH INFORMATION IS AVAILABLE ELECTRONICALLY THROUGH THE COMPANY’S
FILINGS WITH THE SEC, THE COMPANY WILL MAKE AVAILABLE) TO THE HOLDER: 
 (a) as soon as practicable after it is available, one copy of
(i) its Annual Report to Shareholders (which Annual Report shall contain financial statements audited in accordance with generally accepted accounting principles by an independent registered public accounting firm, and (ii) if not included
in substance in the Annual Report to Shareholders, its Annual Report on Form 10-K (the foregoing, in each case, excluding exhibits); 
 (b) upon the reasonable request of the Holder, all exhibits excluded by the parenthetical to subsection (a)(ii) of this Section 5 as filed with the SEC and all other information that is made available to shareholders; and

 (c) upon the reasonable request of the Holder, an adequate number of copies of the Prospectuses to supply to any other party
requiring such Prospectuses; and the Company, upon the reasonable request of the Holder, will meet with the Holder or a representative thereof at the Company’s headquarters during the Company’s normal business hours to discuss all
information relevant for disclosure in the Registration Statement covering the Registrable Securities and will otherwise reasonably cooperate with the Holder conducting an investigation for the purpose of reducing or eliminating the Holder’s
exposure to liability under the Securities Act, including the reasonable production of information at the Company’s headquarters; provided, that the Company shall not be required to disclose any confidential information to or meet at its
headquarters with the Holder until and unless the Holder shall have entered into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, with the Company with respect thereto. 
  

 7 

 6. PIGGY-BACK REGISTRATIONS. 
 (a) If at any time during the Effectiveness Period there is not an effective Registration Statement covering all of the Registrable Securities and
the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or
Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with the
stock option or other employee benefit plans, then the Company shall give prompt written notice to the Holder of Registrable Securities of its intention to do so and of such Holder’s rights under this Section 6. Upon the written request of
any such Holder made within 15 days after the receipt of any such notice (which request shall specify the Registrable Securities intended to be disposed of by such Holder), the Company will use its best efforts to effect the registration under the
Securities Act of all Registrable Securities which the Company has been so requested to register by the Holder thereof, to the extent requisite to permit the disposition of the Registrable Securities to be so registered; provided that
(i) if, at any time after giving written notice of its intention to register any securities and prior to the effective date of the registration statement filed in connection with such registration, the Company shall determine for any reason not
to proceed with the proposed registration of the securities to be sold by it, the Company may, at its election, give written notice of such determination to the Holder of Registrable Securities and, thereupon, shall be relieved of its obligation to
register any Registrable Securities in connection with such registration (but not from its obligation to pay the registration expenses in connection therewith), and (ii) if such registration involves an underwritten offering, the Holder of
Registrable Securities requesting to be included in the Company’s registration must sell their Registrable Securities to the underwriters selected by the Company on the same terms and conditions as apply to the Company, with such differences,
including any with respect to indemnification and liability insurance, as may be customary or appropriate in combined primary and secondary offerings. If a registration requested pursuant to this Section 6(a) involves an underwritten public
offering, the Holder of Registrable Securities requesting to be included in such registration may elect, in writing prior to the effective date of the registration statement filed in connection with such registration, not to register such securities
in connection with such registration. The Company will pay all registration expenses in connection with each registration of Registrable Securities. 
 (b) If a registration pursuant to this Section 6 involves an underwritten offering and the managing underwriter advises the Company in writing that, in its opinion, the number of securities requested to be
included in such registration exceeds the number which can be sold in such offering, so as to be likely to have an adverse effect on the price, timing or distribution of the securities offered in such offering as contemplated by the Company (other
than the Registrable Securities), then the Company will include in such registration (i) first, 100% of the securities the Company proposes to sell and (ii) second, to the extent of the number of Registrable Securities requested to be
included in such registration pursuant to this Section 6 which, in the opinion of such managing underwriter, can be sold without having the adverse effect referred to above, the number of Registrable Securities which the Holder has requested to
be included in such registration. 
 7. LIMITS ON ADDITIONAL ISSUANCES. EXCEPT FOR THE ISSUANCE OF STOCK OPTIONS UNDER THE
COMPANY’S STOCK OPTION PLANS, THE ISSUANCE OF COMMON STOCK UNDER THE COMPANY’S EMPLOYEE STOCK PURCHASE PLAN OR UPON EXERCISE OF OUTSTANDING OPTIONS AND WARRANTS AND THE OFFERING 

  

 8 

 
CONTEMPLATED HEREBY, THE COMPANY WILL NOT, FOR A PERIOD OF SIX (6) MONTHS FOLLOWING THE CLOSING OF THE OFFERING, OFFER OR SELL ANY SECURITIES OF THE
COMPANY UNLESS, IN THE OPINION OF THE COMPANY’S COUNSEL, SUCH OFFER OR SALE DOES NOT JEOPARDIZE THE AVAILABILITY OF EXEMPTIONS FROM THE REGISTRATION AND QUALIFICATION REQUIREMENTS UNDER APPLICABLE SECURITIES LAWS WITH RESPECT TO THE OFFERING.
THE FOREGOING SHALL NOT APPLY TO SECURITIES ISSUED IN CONNECTION WITH ANY ACQUISITION, INCLUDING BY WAY OF MERGER, OR PURCHASE OF STOCK OR ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF ANY THIRD PARTY. EXCEPT FOR THE ISSUANCE OF STOCK OPTIONS UNDER THE
COMPANY’S STOCK OPTION PLANS, THE ISSUANCE OF COMMON STOCK UNDER THE COMPANY’S EMPLOYEE STOCK PURCHASE PLAN OR UPON EXERCISE OF OUTSTANDING OPTIONS AND WARRANTS, THE ISSUANCE OF COMMON STOCK PURCHASE WARRANTS, AND THE OFFERING CONTEMPLATED
HEREBY, THE COMPANY HAS NOT ENGAGED IN ANY SUCH OFFERING DURING THE SIX (6) MONTHS PRIOR TO THE DATE OF THIS AGREEMENT. THE FOREGOING PROVISIONS SHALL NOT PREVENT THE COMPANY FROM FILING A “SHELF” REGISTRATION STATEMENT PURSUANT TO
RULE 415 UNDER THE SECURITIES ACT, BUT THE FOREGOING PROVISIONS SHALL APPLY TO ANY SALE OF SECURITIES THEREUNDER. 
 8. NOTICES. ALL
NOTICES, REQUESTS, CONSENTS AND OTHER COMMUNICATIONS HEREUNDER SHALL BE IN WRITING, SHALL BE DELIVERED (A) IF WITHIN THE UNITED STATES, BY FIRST-CLASS REGISTERED OR CERTIFIED AIRMAIL, OR NATIONALLY RECOGNIZED OVERNIGHT EXPRESS COURIER, POSTAGE
PREPAID, OR BY FACSIMILE, OR (B) IF FROM OUTSIDE THE UNITED STATES, BY INTERNATIONAL FEDERAL EXPRESS (OR COMPARABLE SERVICE) OR FACSIMILE, AND SHALL BE DEEMED GIVEN (I) IF DELIVERED BY FIRST-CLASS REGISTERED OR CERTIFIED MAIL DOMESTIC,
UPON THE BUSINESS DAY RECEIVED, (II) IF DELIVERED BY NATIONALLY RECOGNIZED OVERNIGHT CARRIER, ONE (1) BUSINESS DAY AFTER TIMELY DELIVERY TO SUCH CARRIER, (III) IF DELIVERED BY INTERNATIONAL FEDERAL EXPRESS (OR COMPARABLE SERVICE), TWO
(2) BUSINESS DAYS AFTER TIMELY DELIVERY TO SUCH CARRIER, (IV) IF DELIVERED BY FACSIMILE, UPON ELECTRIC CONFIRMATION OF RECEIPT AND SHALL BE ADDRESSED AS FOLLOWS, OR TO SUCH OTHER ADDRESS OR ADDRESSES AS MAY HAVE BEEN FURNISHED IN WRITING
BY A PARTY TO ANOTHER PARTY PURSUANT TO THIS PARAGRAPH: 
  

	 	(a)	if to the Company, to: 

 eDiets.com, Inc.

 1000 Corporate Drive 
 Suite
600 
 For Lauderdale, FL 33334 
 Attn: General Counsel 
 Tel: (954) 703-6375 
 Fax: (954) 727-2601 
 with a copy to: 
 Edwards Angell Palmer & Dodge, LLP 
 1 N. Clematis Street 
 West Palm Beach, FL 33401 
  

 9 

 
Attn: Leslie J. Croland 
 Tel:
(561) 820-0212 
 Fax: (561) 655-8719 
  

	 	(b)	if to the Holder, at its address on the signature page of this Agreement. 

 9. AMENDMENTS; WAIVER. THIS AGREEMENT MAY NOT BE MODIFIED OR AMENDED EXCEPT PURSUANT TO AN INSTRUMENT IN WRITING SIGNED BY THE COMPANY, THE SELLING STOCKHOLDER AND THE HOLDER. ANY WAIVER OF A PROVISION OF THIS
AGREEMENT MUST BE IN WRITING AND EXECUTED BY THE PARTY AGAINST WHOM ENFORCEMENT OF SUCH WAIVER IS SOUGHT. 
 10. SUCCESSORS AND
ASSIGNS. THIS AGREEMENT SHALL BE BINDING UPON AND INURE TO THE BENEFIT OF THE PARTIES AND THEIR SUCCESSORS AND PERMITTED ASSIGNS. NO PARTY MAY ASSIGN THIS AGREEMENT OR ANY RIGHTS OR OBLIGATIONS HEREUNDER WITHOUT THE PRIOR WRITTEN CONSENT OF THE
OTHER; PROVIDED, HOWEVER, THAT HOLDER MAY ASSIGN ALL OR ANY OF ITS RIGHTS AND OBLIGATIONS HEREUNDER TO ANY AFFILIATE OF HOLDER THAT IS CONTROLLED, DIRECTLY OR INDIRECTLY, BY PRIDES CAPITAL PARTNERS, LLC (ANY SUCH ASSIGNMENT BY THE HOLDER PURSUANT TO
THE PRECEDING PROVISO SHALL NOT, HOWEVER, RELEASE OR BE DEEMED TO RELEASE THE HOLDER FROM ITS OBLIGATIONS HEREUNDER, AND THE HOLDER SHALL REMAIN LIABLE FOR ALL SUCH OBLIGATIONS). 
 11. HEADINGS. THE HEADINGS OF THE VARIOUS SECTIONS OF THIS AGREEMENT HAVE BEEN INSERTED FOR CONVENIENCE OF REFERENCE ONLY AND SHALL NOT BE DEEMED
TO BE PART OF THIS AGREEMENT. 
 12. ENTIRE AGREEMENT; SEVERABILITY. THIS AGREEMENT SETS FORTH THE ENTIRE AGREEMENT AND UNDERSTANDING
OF THE PARTIES RELATING TO THE SUBJECT MATTER HEREOF AND SUPERSEDES ALL PRIOR AND CONTEMPORANEOUS AGREEMENTS, NEGOTIATIONS AND UNDERSTANDINGS BETWEEN THE PARTIES, BOTH ORAL AND WRITTEN RELATING TO THE SUBJECT MATTER HEREOF. IF ANY PROVISION
CONTAINED IN THIS AGREEMENT IS DETERMINED TO BE INVALID, ILLEGAL OR UNENFORCEABLE IN ANY RESPECT, THE VALIDITY, LEGALITY AND ENFORCEABILITY OF THE REMAINING PROVISIONS CONTAINED HEREIN SHALL NOT IN ANY WAY BE AFFECTED OR IMPAIRED THEREBY.

 13. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF
DELAWARE, WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAW. 
 14. COUNTERPARTS. THIS AGREEMENT MAY BE EXECUTED IN TWO OR
MORE COUNTERPARTS, EACH OF WHICH SHALL CONSTITUTE AN ORIGINAL, BUT ALL OF WHICH, WHEN TAKEN TOGETHER, SHALL CONSTITUTE BUT ONE INSTRUMENT, AND SHALL BECOME EFFECTIVE WHEN ONE OR MORE COUNTERPARTS HAVE BEEN SIGNED BY EACH PARTY HERETO AND DELIVERED
TO THE OTHER PARTIES. 
  

 10 

 Please confirm that the foregoing correctly sets forth the agreement between us by signing below.

  

					
	Dated as of May 30, 2008	 	PRIDES CAPITAL FUND I, L.P.
			
		 	By:	 	Prides Capital Partners, LLC, its General Partner
			
		 	By:	 	 /s/ Kevin A. Richardson II

		 	Name:	 	Kevin A. Richardson II
		 	Title:	 	
		
		 	Address:
		 	c/o Prides Capital Partners, LLC
		 	200 High Street, Suite 700
		 	Boston, MA 02110
		 	Attention: Murray Indick
		 	 Telephone: (415) 946-1482
 Facsimile: (415)
946-1486
 Email: murray@pridescapital.com

		
	Dated as of May 30, 2008	 	EDIETS.COM, INC.
			
		 	By:	 	 /s/ James A. Epstein

		 	Name:	 	James A. Epstein
		 	Title:	 	Secretary

 [REGISTRATION RIGHTS AGREEMENT SIGNATURE PAGE] 

 Exhibit A 
 eDiets.com, Inc. 
 CERTIFICATE OF SUBSEQUENT SALE 
 [Transfer Agent] 

											
	  
	  		  		  		  		  	
	  
	  		  		  		  		  	

  

	 	RE:	Sale of Securities of Common Stock of eDiets.com, Inc. (the “Company”) pursuant to the Company’s Prospectus dated
            , 200[-] (the “Prospectus”) 

 Dear Sir/Madam:

 The undersigned hereby certifies, in connection with the sale of shares of Common Stock of the Company included in the table of Selling
Shareholders in the Prospectus, that the undersigned has sold the Shares pursuant to the Prospectus and in a manner described under the caption “Plan of Distribution” in the Prospectus and that such sale complies with all applicable
securities laws, including, without limitation, the Prospectus delivery requirements of the Securities Act of 1933, as amended. 
  

							
	 Selling Shareholder (the beneficial owner):
	 	  

		
	 Record Holder (e.g., if held in name of nominee):
	 	  

		
	 Restricted Stock Certificate No.(s):
	 	  

		
	 Number of Shares Sold:
	 	  

		
	 Date of Sale:
	 	  

 In the event that you receive a stock certificate(s) representing more shares of Common Stock than
have been sold by the undersigned, then you should return to the undersigned a newly issued certificate for such excess shares in the name of the Record Holder and BEARING A RESTRICTIVE LEGEND. Further, you should place a stop transfer on your
records with regard to such certificate. 
  

							
	Dated:
                                    	 		 	Very truly yours,
		 		 	By:	 	  

		 		 	Print Name:	 	  

		 		 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]